Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.

AIM To study the prevalence of HBV and HCV co-infection in patients with HIV attending a referral hospital in Northern India. METHODS AND MATERIAL The study cohort included six hundred and twenty consecutive HIV infected patients who were studied for co-infection with HBV/HCV or both. It included four hundred and seventy two male and one hundred and forty eight female patients between the age group 25-50 years. HBV and HCV infection was diagnosed by ELISA. Other routine investigations were also done. RESULTS Out of a total of 620 consecutive HIV infected patients studied, HBV co-infection was detected in 14/ 620 (2.25%) patients and HCV co-infection in 10/620 (1.61%) patients and dual co-infection (HBV/HCV) in 1/620(0.16%). The mode of transmission of HBV was sexual contact in all (100%), while for HCV it was sexual contact in 5 patients (50%), blood transfusion in 4 patients (40%) and intravenous drug use (IDU) in 1 patient (10%). CONCLUSION The prevalence of co-infection with HBV/HCV is much lower in our study population as compared to that reported in Western literature.

[1]  S. Swaminathan,et al.  Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. , 2006, Journal of postgraduate medicine.

[2]  R. Jones,et al.  HIV and hepatitis C co‐infection , 2005, International journal of clinical practice.

[3]  N. Voirin,et al.  Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992–2002 , 2005, Journal of viral hepatitis.

[4]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[5]  D. Pillay,et al.  HIV and hepatitis C coinfection within the CAESAR study , 2004, HIV medicine.

[6]  D. Chattopadhya,et al.  A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. , 2003, Indian journal of medical microbiology.

[7]  R. Chung,et al.  HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy. , 2001, Antiviral chemistry & chemotherapy.

[8]  R. Detels,et al.  Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. , 2000, The Indian journal of medical research.

[9]  A. Dhanvijay,et al.  Hepatitis B Virus infection in HIV infected patients , 1999 .

[10]  P. Schmid,et al.  Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA , 1999, Journal of viral hepatitis.

[11]  J. Goudsmit,et al.  Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. , 1998, Virology.

[12]  M. Manns,et al.  Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. , 1997, Journal of hepatology.

[13]  M. Leal,et al.  Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. , 1997, Journal of hepatology.

[14]  D. Vlahov,et al.  Correlates of Hepatitis C Virus Infections among Injection Drug Users , 1995, Medicine.

[15]  J. Delfraissy,et al.  Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. , 1988, The Journal of infectious diseases.